M
Membro cancellato 234088
Guest
Immutep Granted New Patents in Japan and South Korea for First-in-Class LAG-3 Candidate, Eftilagimod Alpha in Chemo-Immunotherapy Combination
https://www.stocktitan.net/news/IMM...nd-south-korea-for-first-in-f5ftg8c3msbv.html
https://www.stocktitan.net/news/IMM...nd-south-korea-for-first-in-f5ftg8c3msbv.html